Clinical Trials
10 trialsNCT04154956 2026-05-18
CARMEN-LC03
Sanofi
Phase 3 Terminated
NCT04394624 2025-06-06
CARMEN-LC04
Sanofi
Phase 2 Terminated
NCT04923945 2025-03-07
Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Patients
Hutchmed
Phase 3 Completed
NCT04994795 2024-11-21
DEEP-Lung-IV
Sophia Genetics SAS
Active not recruiting
NCT02443337 2020-12-09
A Study of LY3023414 and Necitumumab in Squamous Lung Cancer
Eli Lilly and Company
Phase 2 Terminated
NCT03477474 2019-10-10
GEODE
Guardant Health, Inc.
Terminated
NCT01703091 2019-09-30
A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer
Eli Lilly and Company
Phase 2 Completed
NCT01935154 2019-06-19
Efficacy Study of Vx001 Vaccine in NSCLC Patients
Vaxon Biotech
Phase 2 Completed
NCT01966003 2017-10-19
Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer
Amgen
Phase 3 Completed
NCT00701558 2016-06-24
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer
Hoffmann-La Roche
Phase 2 Completed